{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1058, 
        1072
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2123, 
        2146
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        975, 
        1002
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        518, 
        547
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2046, 
        2081
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        930, 
        956
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1074, 
        1081
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1094, 
        1095
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1048, 
        1057
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1276, 
        1293
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1084007^CLIA|eMARCPlus|TN Cancer Registry|20170919125846||ORU^R01^ORU_R01|201709191258460001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-ES-012061^PathSys^44D1084007^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170831000000|||||||20170901000000|&Prostate, TUR|1770650145^^^^^^MD^^CMS^D^^^NPI||||||20170905000000|||F||||||C61^Malignant neoplasm of prostate^I10~R97.20^Elevated prostate specific antigen [PSA]^I10|1285672592&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nThe patient's name is \"\" and is identified by requisition and specimen container label. Received in formalin within an intact suction filter trap labeled with the patient's name and \"prostate chips\" is a 10.4 g, 4 x 3 x 2 cm loose aggregate of tan and yellow-brown, focally cauterized pieces of rubbery tissue. The specimen is submitted in its entirety in cassettes 1A-1G. (DSP)\n\n\nPath report.site of origin\n\nProstate chips\n\n\nPath report.final diagnosis\n\nProstate chips (transurethral resection):   Prostatic adenocarcinoma, Gleason pattern 5+4=9 (90% pattern 5, grade group     5).   10.4 g, of tissue, 98% of the tissue is involved by carcinoma.   Extraprostatic fat involvement identified.   Perineural invasion is present. CANCER CHECKLIST: PROSTATE GLAND: Transurethral Prostatic Resection (TUR), Enucleation Specimen (Subtotal Prostatectomy) 2.002.001.1000043 SPECIMEN  Procedure: Transurethral prostatic resection Specimen Size  Weight (g): 10.4 grams Histologic Grade  Gleason Pattern: Gleason pattern (specify)  Primary (predominant) Pattern: Grade 5  Secondary (worst remaining) Pattern: Grade 4  Total Gleason Score: 9,, grade group 5 EXTENT  Tumor Quantitation: TUR Specimens  Proportion (percentage) of Prostatic Tissue Involved by Tumor: 98%  Periprostatic Fat Invasion: Present  Seminal Vesicle Invasion: Not identified ACCESSORY FINDINGS  Lymph-Vascular Invasion: Not identified  Perineural Invasion: Present ADDITIONAL NON-TUMOR  Additional Pathologic Findings: None identified\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Enlarged prostate with lower urinary tract symptoms (N40.1), bladder wall mass, elevated PSA, bilateral hydronephrosis\n\n\n"
}